The stock of Bioamber Inc (NYSE:BIOA) is a huge mover today! The stock decreased 2.83% or $0.12 on October 3, hitting $4.12. About 53,978 shares traded hands or 41.07% up from the average. Bioamber Inc (NYSE:BIOA) has risen 21.18% since March 1, 2016 and is uptrending. It has outperformed by 8.96% the S&P500.
The move comes after 6 months negative chart setup for the $125.94M company. It was reported on Oct, 4 by Barchart.com. We have $3.63 PT which if reached, will make NYSE:BIOA worth $15.11 million less.
Analysts await Bioamber Inc (NYSE:BIOA) to report earnings on November, 2. They expect $-0.22 earnings per share, up 38.89% or $0.14 from last year’s $-0.36 per share. After $-0.25 actual earnings per share reported by Bioamber Inc for the previous quarter, Wall Street now forecasts -12.00% EPS growth.
According to Zacks Investment Research, “BioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in products including plastics, resins, food additives and personal care products. It operates in France, China, Canada, and the United States. BioAmber Inc. is based in Plymouth, Minnesota.”
Insitutional Activity: The institutional sentiment decreased to 0.82 in 2016 Q2. Its down 0.43, from 1.25 in 2016Q1. The ratio fall, as 2 funds sold all Bioamber Inc shares owned while 9 reduced positions. 1 funds bought stakes while 8 increased positions. They now own 11.17 million shares or 8.33% less from 12.19 million shares in 2016Q1.
Goldman Sachs Grp Inc Inc has invested 0% of its portfolio in Bioamber Inc (NYSE:BIOA). Morgan Stanley owns 12,252 shares or 0% of their US portfolio. Raymond James & Associates last reported 21,450 shares in the company. Ardsley Advisory Prns last reported 50,000 shares in the company. Essex Mngmt Lc has 101,362 shares for 0.05% of their US portfolio. Lpl Fin Ltd Liability Corporation has 0% invested in the company for 41,450 shares. Deutsche Fincl Bank Ag holds 294,216 shares or 0% of its portfolio. State Bank Of America De owns 3,537 shares or 0% of their US portfolio. Geode Capital Mngmt Limited Liability has invested 0% of its portfolio in Bioamber Inc (NYSE:BIOA). Bank & Trust Of New York Mellon Corp owns 15,311 shares or 0% of their US portfolio. The Ontario – Canada-based Scotia Capital has invested 0% in Bioamber Inc (NYSE:BIOA). Blackrock Fund Advisors holds 0% of its portfolio in Bioamber Inc (NYSE:BIOA) for 3,413 shares. Winslow Evans & Crocker owns 600 shares or 0% of their US portfolio. Vanguard Gru last reported 106,029 shares in the company. Waddell & Reed Financial holds 0.05% or 8.62M shares in its portfolio.
Insider Transactions: Since May 5, 2016, the stock had 5 insider buys, and 0 selling transactions for $163,102 net activity. BRINER KURT W bought 21,015 shares worth $75,770. Wall Kenneth W. also bought $41,136 worth of Bioamber Inc (NYSE:BIOA) on Monday, May 9. Huc Jean-Francois bought 10,000 shares worth $32,190. Hartmann Michael A. had bought 3,000 shares worth $10,315.
More recent Bioamber Inc (NYSE:BIOA) news were published by: Quotes.Wsj.com which released: “BioAmber Inc. BIOA (US: NYSE)” on April 27, 2013. Also Thestreet.com published the news titled: “Why BioAmber (BIOA) Stock Is Falling In After-Hours Trading Today” on July 15, 2014. Marketwired.com‘s news article titled: “LifeSci Advisors Initiates Coverage of BioAmber Inc (NYSE: BIOA)” with publication date: October 08, 2013 was also an interesting one.
BIOA Company Profile
BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., incorporated on October 15, 2008, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, resins, food additives and personal care products. The Company’s geographical divisions include Europe and North America. The Firm sells its product, bio-succinic acid, to clients in a range of chemical markets. Bio-succinic acid is a biologically produced, chemically identical replacement for petroleum-derived succinic acid that can be utilized to produce derivative products, such as bio 1,4 Butanediol (1,4 BDO), and can substitute petrochemicals, such as maleic anhydride, phthalic acid and adipic acid in various applications. The Company’s bio specialty chemicals can be used in multiple end-markets and applications, and serves as building blocks for a range of products used every day. Bio-succinic acid is used in various applications, including plasticizers, polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals and lubricants, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate (PET).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.